196 related articles for article (PubMed ID: 28689263)
21. Assessing the content, presentation, and readability of dental informed consents.
Glick A; Taylor D; Valenza JA; Walji MF
J Dent Educ; 2010 Aug; 74(8):849-61. PubMed ID: 20679454
[TBL] [Abstract][Full Text] [Related]
22. How do consent forms for diagnostic high-throughput sequencing address unsolicited and secondary findings? A content analysis.
Vears DF; Niemiec E; Howard HC; Borry P
Clin Genet; 2018 Oct; 94(3-4):321-329. PubMed ID: 29888485
[TBL] [Abstract][Full Text] [Related]
23. [Readability of informed consent forms for subjects participating in biomedical research: updating is required].
Paris A; Cracowski JL; Ravanel N; Cornu C; Gueyffier F; Deygas B; Guillot K; Bosson JL; Hommel M
Presse Med; 2005 Jan; 34(1):13-8. PubMed ID: 15685092
[TBL] [Abstract][Full Text] [Related]
24. Readability standards for informed-consent forms as compared with actual readability.
Paasche-Orlow MK; Taylor HA; Brancati FL
N Engl J Med; 2003 Feb; 348(8):721-6. PubMed ID: 12594317
[TBL] [Abstract][Full Text] [Related]
25. Whole Exome Sequencing: Applications in Prenatal Genetics.
Jelin AC; Vora N
Obstet Gynecol Clin North Am; 2018 Mar; 45(1):69-81. PubMed ID: 29428287
[TBL] [Abstract][Full Text] [Related]
26. Informed consent for research: a study to evaluate readability and processability to effect change.
Philipson SJ; Doyle MA; Gabram SG; Nightingale C; Philipson EH
J Investig Med; 1995 Oct; 43(5):459-67. PubMed ID: 8528757
[TBL] [Abstract][Full Text] [Related]
27. Improvement of informed consent and the quality of consent documents.
Jefford M; Moore R
Lancet Oncol; 2008 May; 9(5):485-93. PubMed ID: 18452859
[TBL] [Abstract][Full Text] [Related]
28. Reporting Incidental Findings in Clinical Whole Exome Sequencing: Incorporation of the 2013 ACMG Recommendations into Current Practices of Genetic Counseling.
Smith LA; Douglas J; Braxton AA; Kramer K
J Genet Couns; 2015 Aug; 24(4):654-62. PubMed ID: 25403901
[TBL] [Abstract][Full Text] [Related]
29. Misattributed parentage as an unanticipated finding during exome/genome sequencing: current clinical laboratory practices and an opportunity for standardization.
Eno C; Bayrak-Toydemir P; Bean L; Braxton A; Chao EC; El-Khechen D; Esplin ED; Friedman B; Hagman KDF; Hambuch T; Hernandez A; Juusola J; Londre G; Machado J; Mao R; Mighion L; Rehm HL; Ward P; Deignan JL
Genet Med; 2019 Apr; 21(4):861-866. PubMed ID: 30214068
[TBL] [Abstract][Full Text] [Related]
30. Informed consent for research on stored blood and tissue samples: a survey of institutional review board practices.
White MT; Gamm J
Account Res; 2002; 9(1):1-16. PubMed ID: 12705242
[TBL] [Abstract][Full Text] [Related]
31. Pediatric clinical exome/genome sequencing and the engagement process: encouraging active conversation with the older child and adolescent: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG).
Bush LW; Bartoshesky LE; David KL; Wilfond B; Williams JL; Holm IA;
Genet Med; 2018 Jul; 20(7):692-694. PubMed ID: 29565417
[No Abstract] [Full Text] [Related]
32. Are informed consent forms that describe clinical oncology research protocols readable by most patients and their families?
Grossman SA; Piantadosi S; Covahey C
J Clin Oncol; 1994 Oct; 12(10):2211-5. PubMed ID: 7931491
[TBL] [Abstract][Full Text] [Related]
33. Role and practice evolution for genetic counseling in the genomic era: The experience of Australian and UK genetics practitioners.
Dwarte T; Barlow-Stewart K; O'Shea R; Dinger ME; Terrill B
J Genet Couns; 2019 Apr; 28(2):378-387. PubMed ID: 30629777
[TBL] [Abstract][Full Text] [Related]
34. Informed Consent in the Genomics Era.
Rego S; Grove ME; Cho MK; Ormond KE
Cold Spring Harb Perspect Med; 2020 Aug; 10(8):. PubMed ID: 31570382
[TBL] [Abstract][Full Text] [Related]
35. An analysis of the readability of patient information and consent forms used in research studies in anaesthesia in Australia and New Zealand.
Taylor HE; Bramley DE
Anaesth Intensive Care; 2012 Nov; 40(6):995-8. PubMed ID: 23194208
[TBL] [Abstract][Full Text] [Related]
36. Quantitative and qualitative analysis of study-related patient information sheets in randomised neuro-oncology phase III-trials.
Reinert C; Kremmler L; Burock S; Bogdahn U; Wick W; Gleiter CH; Koller M; Hau P
Eur J Cancer; 2014 Jan; 50(1):150-8. PubMed ID: 24103146
[TBL] [Abstract][Full Text] [Related]
37. Developing a conceptual, reproducible, rubric-based approach to consent and result disclosure for genetic testing by clinicians with minimal genetics background.
Ormond KE; Hallquist MLG; Buchanan AH; Dondanville D; Cho MK; Smith M; Roche M; Brothers KB; Coughlin CR; Hercher L; Hudgins L; Jamal S; Levy HP; Raskin M; Stosic M; Uhlmann W; Wain KE; Currey E; Faucett WA
Genet Med; 2019 Mar; 21(3):727-735. PubMed ID: 29976988
[TBL] [Abstract][Full Text] [Related]
38. How well informed is the informed consent for cancer clinical trials?
Malik L; Kuo J; Yip D; Mejia A
Clin Trials; 2014 Dec; 11(6):686-8. PubMed ID: 25135910
[TBL] [Abstract][Full Text] [Related]
39. Consent documents for oncology trials: does anybody read these things?
Sharp SM
Am J Clin Oncol; 2004 Dec; 27(6):570-5. PubMed ID: 15577434
[TBL] [Abstract][Full Text] [Related]
40. Genetic counseling practice in next generation sequencing research: implications for the ethical oversight of the informed consent process.
Egalite N; Groisman IJ; Godard B
J Genet Couns; 2014 Aug; 23(4):661-70. PubMed ID: 24664856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
